BGP Advisors co-founder Ruth Epstein was featured by Bloomberg this week in an article about investing opportunities in the cannabis space.
When asked why the Medmen Opportunity Fund II stood out among many investment alternatives in the space, Epstein is quoted as saying, "They were looking at markets where there was a lot of disruption and where there’s not a lot of transparency."
The article, penned by Jennifer Kaplan, notes what many experienced investors appreciate about MedMen - the Wall Street bona fides of its co-chairman, Chris Leavy. Leavy served as chief investment officer of fundamental equities at BlackRock, the world’s largest money manager. Before that, he was chief investment officer of equities at OppenheimerFunds.
The presence of Leavy, 46, who took one of the biggest stakes in MedMen’s first fund, is a big deal for investors who might otherwise be hesitant about a cannabis fund, Epstein said.
“That was the thing that really pushed me to pull the trigger,” she said.